Clinical trial
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
NCT00465270 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00465270 |
|---|---|
| Title | Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial |
| Official title | Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT) |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cryptogenic Stroke |
| Intervention type | Device, Other |
| Interventions | AMPLATZER PFO Occluder, Standard of Care - Medical Management |
| Enrollment | 980 |
| Start date | Aug 1, 2003 |
| Primary completion | May 1, 2012 |
| Completion | May 1, 2016 |
| First posted | Apr 24, 2007 |
| Last update posted | Feb 18, 2019 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: